Peer Review History
| Original SubmissionApril 29, 2020 |
|---|
|
PONE-D-20-12312 Comparative RNA-Seq Analyses of Drosophila Plasmatocytes Reveal Gene Specific Signatures In Response To Clean Injury And Septic Injury PLOS ONE Dear Bruno, Thank you for submitting your manuscript to PLOS ONE. It has now been evaluated by three expert reviewers. They all liked the work, but suggested minor revisions to further improve it. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised by the reviewers in their reviews. The reviewers had trouble accessing all supplemental figures. When I tried, I was only able to download three of the seven supplemental figures. I don't know the cause of this (could be a glitch in the Plos One editorial manager). Please make sure when uploading the revision that all figures upload successfully. We would appreciate receiving your revised manuscript within two months. If you need more time, please let us know. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Andreas *** Andreas Bergmann, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you are reporting an analysis of a microarray, next-generation sequencing, or deep sequencing data set. PLOS requires that authors comply with field-specific standards for preparation, recording, and deposition of data in repositories appropriate to their field. Please upload these data to a stable, public repository (such as ArrayExpress, Gene Expression Omnibus (GEO), DNA Data Bank of Japan (DDBJ), NCBI GenBank, NCBI Sequence Read Archive, or EMBL Nucleotide Sequence Database (ENA)). In your revised cover letter, please provide the relevant accession numbers that may be used to access these data. For a full list of recommended repositories, see http://journals.plos.org/plosone/s/data-availability#loc-omics or http://journals.plos.org/plosone/s/data-availability#loc-sequencing. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The experimental set-up is simple, straight forward and strategic. All possible combinations were investigated and the findings well discussed in the light of the literature. The datasets will provide a basis for further studies on possible differential interaction among hemocyte (plasmatocyte) subsets in the immune response to S. aureus and E. coli. The studies comprehensive describe the functions of the differentially expressed genes and activation networks. The figures are of good quality and informative. The differences in gene expression pattern in the response to S. aureus and E. coli could be elaborated a bit more. Maybe a figure (direct comparison) could help to make the findings and conclusions more transparent. Reviewer #2: In this study, Lemaitre and colleagues have analyzed plasmatocyte-specific transcriptome profiles of Hml-positive plasmatocytes in the wild type, after clean injury, or septic injuries with Gram(-) or Gram(+) bacterium. This study is especially interesting in that immediate early transcriptional changes upon injury or infection, which do not accompany the hemocyte differentiation and are important for initiating immune reactions, are profiled for the first time. Though single-cell transcriptome analyses recently performed by other groups show hemocyte-specific RNA expressions at a single cell level, this study supplements additional insights – septic injuries in particular – into our current knowledge and itself will be a valuable resource to the community in the future. <major points=""> 1. The authors profiled Hml+ plasmatocytes by FACS sorting and compared transcriptomes of wild-type whole larvae to unchallenged hemocytes, and showed that there are hemocyte-specific gene expressions. However, some of the hemocyte-specific genes isolated in Hml+ hemocyte/whole larvae comparison could have been arisen due to the FACS sorting. To validate that FACS sorting itself does not influence the gene expression (or does exert minor alterations), although the hemocyte lineage is not changed, it will be important to add unsorted whole hemocyte transcriptome as an extra control. Several studies have released the whole RNA transcriptome of wild-type hemocytes, including the recent single-cell studies (Tattikota et al., and Cattenoz et al.,), and data are readily available for the analysis. 2. Though 45 minutes is short and may not be enough to induce differentiation of plasmatocytes, the proportion or the level of Hml may already be declining upon clean or septic injury. Is the level or the proportion of Hml+ plasmatocytes unchanged upon injury or infection? While manipulating the FACS sorting, the authors might have already noticed the information in the FACS sorting window as shown in Fig1. <minor points=""> 1. “Drosophila” needs to be italicized in line 37, 46, 73, and others. 2. line 122: 20.000, 30.000 period to a comma 3. Please match the way of writing numbers; for example, line 146: 6723, line 153: 4,477 4. add references in line 289. 5. In addition to the comparisons between EcH/clean injury and SaH/clean injury, which identify EcH- or SaH-specific gene expressions, it will be interesting to compare EcH and SaH to provide ample information on the common immune responsive genes. 6. I assume that all the analyses were done with circulating hemocytes, not the total hemocytes including sessile populations. I might have missed, but there is no information as to which population in specific was used in this study. Reviewer #3: The manuscript by Ramond et al describes the transcriptome of Drosophila hemocytes after clean wounding and immunization with E.coli and S.aureus compared to unchallenged samples. Thus the manuscript joins a series of papers/manuscripts with a similar focus (Cho et al; Tattikota et al; Cattenoz et al), which are cited by the authors. This includes the manuscripts on BioArchives. The similarities between the studies are indicated, so altogether this is a relevant and important contribution to cellular insect immunology. One drawback of this study – admitted by the authors - is the use of only one time point for collecting hemocytes. I only wondered whether when discussing FGF signaling and Pyramus, one should refer to the Tattikota manuscript, since the authors also observe FGF signaling (breathless and branchless) as an important contribution to hemocyte activation. One important point: I could not access supplemental Figs. S4 and following and Fig. S3 does not seem to be labeled. Maybe there was a problem with downloading, although I tried different browsers. So my judgment is based on the GO enrichments. Minor comments: I would include the reference from the Hultmark group (Anderl et al) both when it comes to transdifferentiation/hemocyte subpopulations and perhaps some of the methodological aspects, for example they optimized FACS. Line 80, should the second Rizki be capital? Line 99; Fu et al. lacks year and the reference look strange in the RefList Line 162: here I wonder about secreted immune proteins that lack a signal peptide, it is mentioned later on (when discussing Attacin-D) but since leaderless proteins are a major fraction of insect immune proteins…? Line 264: I think lectin function during fly development is better characterized maybe one such say “immune function of lectins in flies is poorly characterized” In Fig 2B ‘Number of elements: specific (1) or shared by 2, 3, ... lists’. The numbers are not clearly visible perhaps changing the Font color to black might make it easier to see. </minor></major> ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Comparative RNA-Seq Analyses of Drosophila Plasmatocytes Reveal Gene Specific Signatures In Response To Clean Injury And Septic Injury PONE-D-20-12312R1 Dear Bruno, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Thank you for sending your work to PLOS ONE! Kind regards, Andreas ********** Andreas Bergmann, Ph.D. Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-20-12312R1 Comparative RNA-Seq Analyses of Drosophila Plasmatocytes Reveal Gene Specific Signatures In Response To Clean Injury And Septic Injury Dear Dr. Lemaitre: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Andreas Bergmann Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .